Characterization of simian and human immunodeficiency chimeric viruses re-isolated from vaccinated macaque monkeys after challenge infection

Archives of Virology

Volumn 147, Issue 6, 2002, Pages 1091-1104

  Kwofie, T B ^a   Miura, T ^a   Ibuki, K ^a   Enose, Y ^a   Suzuki, H ^a   Ui, M ^a   Kuwata, T ^a   Hayami, M ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; MACACA; SIMIAE; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LIVE VACCINE; NEF PROTEIN; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL; ARTICLE; CELL LINE; CHIMERA; CYTOPATHOGENIC EFFECT; GENETICS; GIANT CELL; HETERODUPLEX ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MACACA; MONKEY DISEASE; PATHOGENICITY; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VIROLOGY; VIRUS REPLICATION;

AIDS VACCINES; ANIMALS; CELL LINE; CHIMERA; CYTOPATHOGENIC EFFECT, VIRAL; GENE PRODUCTS, NEF; GIANT CELLS; HETERODUPLEX ANALYSIS; HIV INFECTIONS; HIV-1; HUMANS; MACACA MULATTA; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VACCINES, ATTENUATED; VIRUS REPLICATION;

EID: 0035983224     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-002-0811-9     Document Type: Article

References (30)

1. Effect of SIVmac infection on peripheral blood CD4 + CD8+ T lymphocytes in cynomolgus macaques
2. The appearance of escape variants in vivo does not account of recombinant envelope vaccines to protect against simian immunodeficiency virus
3. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection
4. Pathogenicity of live attenuated SIV after mucosal infection of neonatal macaques
5. Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques
6. What is required of an HIV vaccine
7. Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys
8. Why do we not have an HIV vaccine and how can we make one?
9. Human immunodeficiency virus infection of monocytic and T-lymphocytic cells: Receptor modulation and differentiation induced by phober ester
10. Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoprotains of HIV type 1
11. Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp 130 does not protect from challenge infection
12. Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques
13. Evidence for recombination of live, attenuated immunodeficiency virus vaccine with challenge virus to a more virulent strain
14. SF33A: Correlation to in vivo outcome
15. Persistent infection with SIVmac chimeric virus having tat, rev, vpu, env, and nef of HIV type 1 in macaque monkeys
16. Protection of monkeys vaccinated with vpr-and/or nef-defective simian immunodeficiency virus strain mac/human immunodeficiency type 1 chimeric viruses: A potential candidate live-attenuated human AIDS vaccine
17. Infectivity and immunogenicity of SIVmac/HIV-1 chimeric viruses (SHIVs) with deletions in two or three genes (vpr, nef and vpx)
18. Importance of the nef gene for maintenance of high virus loads and for development of AIDS
19. Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication
20. Chimeric viruses between SIVmac and various HIV-1 isolates have biological properties that are similar to those of the parental HIV-1
21. Progress in the development of an HIV-1 vaccine
22. The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection
23. Can the immune response control HIV infection?
24. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys
25. Encouraging vaccine results from primate models of HIV type 1 infection
26. Potential pitfalls on the road to an effective HIV vaccine
27. Isolation and characterization of a syncytium-inducing, macrophage/T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo
28. A genetic and viral load analysis of the simian immunodeficiency virus during the acute phase in macaques inoculated by the vaginal route
29. Protection of macaques against a SHIV with homologous HIV-1 env and a Pathogenic SHIV 89.6 P with a Heterologous env by vaccination with multiple gene-deleted SHIVs
30. Prospects for an HIV vaccine